What is the recommended dose of nitroglycerin (NTG) for managing uterine inversion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin Dosing for Uterine Inversion Management

For management of uterine inversion, nitroglycerin should be initiated with incremental doses of intravenous nitroglycerin at 50-100 mcg boluses, or alternatively as sublingual (metered dose spray) nitroglycerin to achieve uterine relaxation while minimizing potential complications such as hypotension. 1

Administration Routes and Dosing

  • Intravenous administration is the preferred route for rapid uterine relaxation in emergency situations such as uterine inversion 2
  • Initial IV bolus dose of 100-200 mcg has been shown to provide effective uterine relaxation in clinical studies 2
  • Sublingual nitroglycerin can be considered as an alternative when IV access is not immediately available 1
  • Incremental dosing approach is recommended to minimize adverse effects while achieving adequate uterine relaxation 1

Mechanism of Action and Efficacy

  • Nitroglycerin causes rapid uterine relaxation through smooth muscle relaxation, facilitating manual correction of uterine inversion 3, 2
  • In vitro studies demonstrate dose-dependent inhibition of both spontaneous and oxytocin-induced myometrial contractile activity 2
  • Complete muscular relaxation can be achieved at concentrations of 25-50 mcg/ml in laboratory settings 2
  • Clinical studies show rapid and effective uterine relaxation following intravenous injection of 100-200 mcg nitroglycerin 2

Clinical Applications and Alternatives

  • Nitroglycerin may be used as an alternative to terbutaline sulfate or general endotracheal anesthesia with halogenated agents for uterine relaxation 1
  • The American Society of Anesthesiologists guidelines recommend nitroglycerin for uterine relaxation during obstetric emergencies like uterine inversion 1
  • Intravenous nitroglycerin has been successfully used to permit replacement of a contracted, completely prolapsed, inverted uterus 3
  • For cases involving major maternal hemorrhage, general anesthesia with an endotracheal tube may be preferable to nitroglycerin 1

Monitoring and Precautions

  • Close monitoring of maternal blood pressure is essential as hypotension is a common side effect 1, 2
  • Systolic blood pressure should generally not be allowed to drop below 90 mmHg 1
  • Nitroglycerin is contraindicated after the use of sildenafil within 24 hours or tadalafil within 48 hours due to risk of profound hypotension 1, 4
  • After achieving uterine repositioning, oxytocin should be administered to restore uterine tone and prevent recurrence of inversion 5
  • Hemodynamic status should be assessed before administering nitroglycerin, particularly in patients with significant blood loss 1

Potential Adverse Effects

  • Maternal hypotension is the most common side effect, which may require treatment with vasopressors such as ephedrine 5
  • Transient decreases in blood pressure of approximately 20% have been reported following nitroglycerin administration 5
  • Headache may occur but is less concerning in the emergency setting of uterine inversion 1
  • The short duration of action of nitroglycerin (minutes) limits prolonged adverse effects 5, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous nitroglycerin for rapid uterine relaxation.

Acta obstetricia et gynecologica Scandinavica, 1998

Guideline

Nitroglycerin Dosing in Sympathetic Crashing Acute Pulmonary Edema (SCAPE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Alternating nitroglycerin and syntocinon to facilitate uterine exploration and removal of an adherent placenta.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.